Satellos Bioscience (MSLE) Divestments (2026)
Satellos Bioscience (MSLE) posted quarterly Divestments of -$33.3 million for Q1 2026.
Satellos Bioscience (MSLE) Divestments (2026) Analysis & Trends
Satellos Bioscience (MSLE) has reported Divestments for 1 consecutive years, with -$33.3 million the latest figure, recorded in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.57 Bn | 130.72 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.99 Bn | 77.99 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 65.00 Bn | 59.82 Bn | 1.37 Bn | - |
| 4 | Moderna | 56.27 Bn | 51.13 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.00 Bn | 36.90 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.60 Bn | 28.29 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.68 Bn | 9.29 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.43 Bn | 26.27 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.34 Bn | 26.51 Bn | - | -13.21 Mn |
| 10 | Satellos Bioscience | 207.48 Mn | 207.48 Mn | - | -3.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -33.34 Mn |